- Q2 2023 Biosyent Inc Earnings Call TranscriptAug 22, 2023$5.54Earnings
- Q1 2023 Biosyent Inc Earnings Presentation TranscriptMay 26, 2023
- Q4 2022 Biosyent Inc Earnings Call TranscriptMar 21, 2023$5.32Earnings
- Biosyent Inc at Issuer Direct Planet MicroCap Showcase (Virtual) TranscriptDec 07, 2022
- Q3 2022 Biosyent Inc Earnings Presentation TranscriptNov 16, 2022
- Q2 2022 Biosyent Inc Earnings Presentation TranscriptAug 23, 2022
- Q1 2022 Biosyent Inc Earnings Presentation TranscriptMay 18, 2022
- Q4 2021 Biosyent Inc Earnings Presentation TranscriptMar 09, 2022
- Q3 2021 Biosyent Inc Earnings Call TranscriptNov 18, 2021$5.71Earnings
- Q2 2021 Biosyent Inc Earnings Call TranscriptAug 25, 2021$6.12 (-2.99%)Earnings
- Q1 2021 Biosyent Inc Earnings Call TranscriptMay 27, 2021$6.19Earnings
- Biosyent Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- Q4 2020 Biosyent Inc Earnings Call TranscriptMar 17, 2021$5.76 (-1.71%)Earnings
- Q3 2020 Biosyent Inc Earnings Call TranscriptNov 26, 2020Earnings
- Q2 2020 Biosyent Inc Earnings Call TranscriptAug 26, 2020$5.24 (+0.13%)Earnings
- Q1 2020 Biosyent Inc Earnings Presentation TranscriptMay 28, 2020
- Q3 2019 Biosyent Inc Earnings Call TranscriptNov 20, 2019$4.99 (+13.41%)Earnings
- Q2 2019 Biosyent Inc Earnings Call TranscriptAug 23, 2019$4.52 (-9.60%)Earnings
- Q1 2019 Biosyent Inc Earnings Call TranscriptMay 29, 2019$5.84 (-3.15%)Earnings
- Q4 2018 Biosyent Inc Earnings Call TranscriptMar 20, 2019$6.2 (+0.81%)Earnings
Biosyent Inc Annual Shareholders Meeting Transcript
© -
Good morning. The meeting will now come to order. My name is René Goehrum, Chairman of the Board of Directors of the company. Welcome to the Annual General and Special Meeting of the shareholders of BioSyent Inc. This meeting is also being webcast live on the BioSyent Inc. corporate website.
Welcome to those shareholders viewing this meeting by webcast. You've been muted. But you will have an opportunity to submit questions following the formal portion of the meeting. If you get disconnected for any reason during the meeting, simply click on the webcast link available on the biosyent.com homepage to reconnect.
With the consent of the meeting, I will act as Chairman; and Robert March, the Chief Financial Officer of the company, will act as secretary of the meeting.
Also joining us here today in person are directors, Mr. Peter Lockhard, and Mr. Steve Wilton. With the concurrence of the meeting, I appoint Roxanne Parsaud of Computershare to act as the scrutineer.
The notice calling this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)